| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443731 | European Journal of Cancer | 2014 | 11 Pages |
Abstract
Vemurafenib can be safely used in patients with advanced symptomatic melanoma that has metastasised to the brain and can result in meaningful tumour regression.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Reinhard Dummer, Simone M. Goldinger, Christian P. Turtschi, Nina B. Eggmann, Olivier Michielin, Lada Mitchell, Luisa Veronese, Paul René Hilfiker, Lea Felderer, Jeannine D. Rinderknecht,